tiprankstipranks
Alaunos Therapeutics Announces Executive Financial Leadership Changes
PremiumCompany AnnouncementsAlaunos Therapeutics Announces Executive Financial Leadership Changes
1y ago
Alaunos Therapeutics Regains Nasdaq Listing Compliance
Premium
Company Announcements
Alaunos Therapeutics Regains Nasdaq Listing Compliance
1y ago
ZIOPHARM Oncology trading halted, news pending
Premium
The Fly
ZIOPHARM Oncology trading halted, news pending
1y ago
Laidlaw downgrades Alaunos to Hold on ‘uncertain future’
PremiumThe FlyLaidlaw downgrades Alaunos to Hold on ‘uncertain future’
2y ago
Alaunos Therapeutics downgraded to Hold from Buy at Laidlaw
Premium
The Fly
Alaunos Therapeutics downgraded to Hold from Buy at Laidlaw
2y ago
Alaunos Therapeutics reports Q2 EPS (4c), consensus (4c)
Premium
The Fly
Alaunos Therapeutics reports Q2 EPS (4c), consensus (4c)
2y ago
Precigen amends exclusive license agreement with Alaunos Therapeutics
PremiumThe FlyPrecigen amends exclusive license agreement with Alaunos Therapeutics
2y ago
Alaunos Therapeutics appoints Hofmeister to board of directors
Premium
The Fly
Alaunos Therapeutics appoints Hofmeister to board of directors
2y ago
Alaunos Therapeutics assumed with an Overweight at Wells Fargo
Premium
The Fly
Alaunos Therapeutics assumed with an Overweight at Wells Fargo
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100